Background: Illness perceptions have been shown to be important determinants of functional and psychosocial outcomes, including quality of life and treatment adherence in end-stage renal disease patients. The aim of this prospective study was to determine whether haemodialysis patients’ illness perceptions impact upon survival. Methods: Haemodialysis patients from a UK renal service completed the Revised Illness Perception Questionnaire. Over the study period (May 2007 to December 2010), all-cause mortality was recorded as the endpoint. Results: 223 patients were followed up for a median of 15.9 months (min. 10 days, max. 42.7 months). The median dialysis vintage was 17.6 months (min. 4 days, max. 391.3 months). Treatment control perceptions demonstrated a significant association with mortality (HR = 0.91, 95% CI: 0.83–0.99, p = 0.03). After controlling for covariates, including age, albumin, extra renal comorbidity and depression scores, perception of treatment control remained a significant predictor of mortality (HR = 0.89, 95% CI: 0.80–0.99, p = 0.03). Conclusions: Patients’ perceptions of treatment control (dialysis therapy) predict survival independently of survival risk factors, including comorbidity. Studies are required to test whether psychological interventions designed to modify maladaptive illness perceptions influence clinical outcomes in this patient setting.

Keywords:
End-stage renal disease, Dialysis, Mortality, Illness perception, Illness representations
1.
Kimmel PL, Weihs K, Peterson RA: Survival in hemodialysis patients: the role of depression. J Am Soc Nephrol 1993;4:12–27.
2.
Christensen AJ, Ehlers SL: Psychological factors in end-stage renal disease: an emerging context for behavioral medicine research. J Consult Clin Psychol 2002;70:712–724.
3.
Kimmel PL, Peterson RA, Weihs KL, et al: Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney Int 2000;57:2093–2098.
4.
Hedayati SS, Bosworth HB, Briley LP, et al: Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression. Kidney Int 2008;74:930–936.
5.
Lopes AA, Bragg J, Young E, et al: Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int 2002;62:199–207.
6.
Chilcot J, Davenport A, Wellsted D, Firth J, Farrington K: An association between depressive symptoms and survival in incident dialysis patients. Nephrol Dial Transplant 2010, E-pub ahead of print.
7.
Steptoe A: Depression and the development of coronary heart disease; in Steptoe A (ed): Depression and Physical Illness. Cambridge, Cambridge University Press, 2007, pp 53–86.
8.
Lesperance F, Frasure-Smith N, Talajic M, Bourassa MG: Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 2002;105:1049–1053.
9.
Chilcot J, Wellsted D, Farrington K: Illness representations are associated with fluid nonadherence among hemodialysis patients. J Psychosom Res 2010;68:203–212.
10.
O’Connor SM, Jardine AG, Millar K: The prediction of self-care behaviors in end-stage renal disease patients using Leventhal’s Self-Regulatory Model. J Psychosom Res 2008;65:191–200.
11.
Weinman J, Petrie KJ, Sharpe N, Walker S: Causal attributions in patients and spouses following first-time myocardial infarction and subsequent lifestyle changes. Br J Health Psychol 2000;5:263–273.
12.
Timmers L, Thong M, Dekker FW, et al: Illness perceptions in dialysis patients and their association with quality of life. Psychol Health 2008;23:679–690.
13.
Griva K, Jayasena D, Davenport A, Harrison M, Newman SP: Illness and treatment cognitions and health related quality of life in end stage renal disease. Br J Health Psychol 2009;14:17–34.
14.
Dickens C, McGowan L, Percival C, et al: New onset depression following myocardial infarction predicts cardiac mortality. Psychosom Med 2008;70:450–455.
15.
Jopson NM, Moss-Morris R: The role of illness severity and illness representations in adjusting to multiple sclerosis. J Psychosom Res 2003;54:503–511, discussion 513–514.
16.
Juergens MC, Seekatz B, Moosdorf RG, Petrie KJ, Rief W: Illness beliefs before cardiac surgery predict disability, quality of life, and depression 3 months later. J Psychosom Res 2010;68:553–560.
17.
Petrie KJ, Weinman J, Sharpe N, Buckley J: Role of patients’ view of their illness in predicting return to work and functioning after myocardial infarction: longitudinal study. BMJ 1996;312:1191–1194.
18.
Bijsterbosch J, Scharloo M, Visser AW, et al: Illness perceptions in patients with osteoarthritis: change over time and association with disability. Arthritis Rheum 2009;61:1054–1061.
19.
Scharloo M, Kaptein AA, Weinman J, Bergman W, Vermeer BJ, Rooijmans HG: Patients’ illness perceptions and coping as predictors of functional status in psoriasis: a 1-year follow up. Br J Dermatol 2000;142:899–907.
20.
Hagger MS, Orbell S: A meta-analytic review of the common-sense model of illness representations. Psychol Health 2003;18:141–184.
21.
Moss-Morris R, Weinman J, Petrie KJ, Horne R, Cameron LD, Buick D: The Revised Illness Perception Questionnaire (IPQ-R). Psychol Health 2002;17:1–16.
22.
Lau RR, Hartman KA: Common sense representations of common illnesses. Health Psychol 1983;2:167–185.
23.
Lau RR, Bernard TM, Hartman KA: Further explorations of common-sense representations of common illnesses. Health Psychol 1989;8:195–219.
24.
Leventhal H, Meyer D, Nerenz D: The common sense representation of illness danger; in Rachman S (ed): Contributions to Medical Psychology. New York, Pergamon Press, 1980, vol 2, pp 7–30.
25.
Leventhal H, Nerenz DR, Steele DJ: Illness representations and coping with health threats; in Baum A, Taylor SE, Singer JE (eds): Handbook of Psychology and Health. Hillsdale, Lawrence Erlbaum Associates, 1984, vol 4, pp 219–252.
26.
van Dijk S, Scharloo M, Kaptein AA, et al: Patients’ representations of their end-stage renal disease: relation with mortality. Nephrol Dial Transplant 2009;24:3183–3185.
27.
Petrie KJ, Cameron LD, Ellis CJ, Buick D, Weinman J: Changing illness perceptions after myocardial infarction: an early intervention randomized controlled trial. Psychosom Med 2002;64:580–586.
28.
Broadbent E, Ellis CJ, Thomas J, Gamble G, Petrie KJ: Further development of an illness perception intervention for myocardial infarction patients: a randomized controlled trial. J Psychosom Res 2009;67:17–23.
29.
Gotch FA: Kinetic modeling in hemodialysis; in Nissenson AR, Fine RN, Gentile DE (eds): Clinical Dialysis. Norwalk, Appleton & Lange, 1995, pp 156–188.
30.
Karnofsky DA, Abelmann HA, Craver LF, Burchenal JH: The use of the nitrogen mustards in the palliative treatment of carcinoma with particular reference to bronchogenic carcinoma. Cancer 1948;1:634–656.
31.
Chandna SM, Schulz J, Lawrence C, Greenwood RN, Farrington K: Is there a rationale for rationing chronic dialysis? A hospital-based cohort study of factors affecting survival and morbidity. BMJ 1999;318:217–223.
32.
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561–571.
33.
Beck AT, Steer RA, Brown GK: Beck Depression Inventory – 2nd Edition Manual. San Antonio, The Psychological Corporation, 1996.
34.
Watnick S, Wang PL, Demadura T, Ganzini L: Validation of 2 depression screening tools in dialysis patients. Am J Kidney Dis 2005;46:919–924.
35.
Craven JL, Rodin GM, Littlefield C: The Beck Depression Inventory as a screening device for major depression in renal dialysis patients. Int J Psychiatry Med 1988;18:365–374.
36.
Beck AT, Steer RA, Garbin MG: Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 1988;8:77–100.
37.
Hedayati SS, Bosworth HB, Kuchibhatla M, Kimmel PL, Szczech LA: The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. Kidney Int 2006;69:1662–1668.
38.
Chilcot J, Wellsted D, Farrington K: Screening for depression while patients dialyse: an evaluation. Nephrol Dial Transplant 2008;23:2653–2659.
39.
Grant D, Almond MK, Newnham A, Roberts P, Hutchings A: The Beck Depression Inventory requires modification in scoring before use in a haemodialysis population in the UK. Nephron Clin Pract 2008;110:c33–c38.
40.
Leventhal H, Diefenbach M, Leventhal EA: Illness cognition – using common-sense to understand treatment adherence and affect cognition interactions. Cogn Ther Res 1992;16:143–163.
41.
French DP, Cooper A, Weinman J: Illness perceptions predict attendance at cardiac rehabilitation following acute myocardial infarction: a systematic review with meta-analysis. J Psychosom Res 2006;61:757–767.
42.
Leventhal H, Leventhal EA, Contrada RJ: Self-regulation, health, and behavior: a perceptual-cognitive approach. Psychol Health 1998;13:717–733.
43.
Fowler C, Baas LS: Illness representations in patients with chronic kidney disease on maintenance hemodialysis. Nephrol Nurs J 2006;33:173–186.
44.
Drayer RA, Piraino B, Reynolds CF 3rd, et al: Characteristics of depression in hemodialysis patients: symptoms, quality of life and mortality risk. Gen Hosp Psychiatry 2006;28:306–312.
45.
Kimmel PL, Peterson RA, Weihs KL, et al: Psychosocial factors, behavioral compliance and survival in urban hemodialysis patients. Kidney Int 1998;54:245–254.
46.
Boulware LE, Liu Y, Fink NE, et al: Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causality. Clin J Am Soc Nephrol 2006;1:496–504.
47.
Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 1996;49:1379–1385.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.